PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Nov 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-11-15

Reporting Person: Levinson Mitchell E. (Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-15	Common Stock	P	461	$5.832	Acquired	69227	Direct
2023-11-15	Common Stock	P	3800	$5.88	Acquired	73027	Direct
2023-11-15	Common Stock	P	5000	$5.9399	Acquired	9135	Indirect
2023-11-15	Common Stock	P	200	$5.92	Acquired	934	Indirect
2023-11-15	Common Stock	P	2300	$5.9399	Acquired	3234	Indirect
2023-11-15	Common Stock	P	100	$5.94	Acquired	834	Indirect
2023-11-15	Common Stock	P	2400	$5.8457	Acquired	3234	Indirect
2023-11-15	Common Stock	P	100	$5.90	Acquired	834	Indirect
2023-11-15	Common Stock	P	2400	$5.80260	Acquired	3234	Indirect
2023-11-15	Common Stock	P	1039	$6.1332	Acquired	1039	Indirect